These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22127954)

  • 1. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
    Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
    Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.
    Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ
    Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.
    Tan TL; Ahmad NS; Nasuruddin DN; Ithnin A; Tajul Arifin K; Zaini IZ; Wan Ngah WZ
    PLoS One; 2016; 11(3):e0152065. PubMed ID: 27003588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
    Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.
    Lu S; Dong Z
    Int J Oncol; 2017 Jun; 50(6):2113-2122. PubMed ID: 28440478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.
    Menschikowski M; Hagelgans A; Schuler U; Froeschke S; Rosner A; Siegert G
    Pathol Oncol Res; 2013 Oct; 19(4):839-46. PubMed ID: 23722320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
    Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
    Gregory CW; Whang YE; McCall W; Fei X; Liu Y; Ponguta LA; French FS; Wilson EM; Earp HS
    Clin Cancer Res; 2005 Mar; 11(5):1704-12. PubMed ID: 15755991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory phospholipase A
    Chovatiya GL; Sarate RM; Sunkara RR; Gawas NP; Kala V; Waghmare SK
    Sci Rep; 2017 Sep; 7(1):11619. PubMed ID: 28912581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
    Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
    Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
    Wang M; Hao FY; Wang JG; Xiao W
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
    Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
    Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of lipid profile by secretory phospholipase A2 group IIA: Verification with a transgenic mouse model.
    Liang L; Song J; Miao S; Xie Q; Li W; Huang H; Shen D; Zhang W
    Biochem Biophys Res Commun; 2024 Jun; 712-713():149955. PubMed ID: 38640737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.